Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?

By Azoulay Élie   Delclaux Christophe  

Intensive Care Medicine, Vol. 30, Iss. 1, 2004-01 ,pp. : 10-17

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 7, 2015-07 ,pp. : 1046-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis

By Greenwald M.   Peloso P.M.   Mandel D.   Soto O.   Frontera N.   Boice J.A.   Zhan X.J.   Curtis S.P.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 2033-2042

Informa Healthcare

Access to resources Recommend Favorite

The effect of montelukast on early‐life wheezing: A randomized, double‐blinded placebo‐controlled study

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 29, Iss. 1, 2018-02 ,pp. : 50-57

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outpatient Treatment of Neutropenic Fever with Oral Antibiotics and Granulocyte Colony-Stimulating Factor

By  

Oncology, Vol. 57, Iss. 2, 1999-08 ,pp. : 127-130

Karger

Access to resources Recommend Favorite